Histopathological changes associated with high intensity focused ultrasound (HIFU) treatment for localised adenocarcinoma of the prostate

Journal of Clinical Pathology

Volumn 53, Issue 5, 2000, Pages 391-394

  Van Leenders, G J L H ^a   Beerlage, H P ^a   Ruijter, E Th ^a   De La Rosette, J J M C H ^a   Van De Kaa, C A ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

High intensity focused ultrasound treatment; Prostate cancer

Indexed keywords

CYTOKERATIN; KI 67 ANTIGEN; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CELL DAMAGE; CELL ORGANELLE; CLINICAL ARTICLE; CYTOPLASM; ELECTRON MICROSCOPY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE EPITHELIUM; PROSTATECTOMY; RADIATION NECROSIS; ULTRASOUND THERAPY; ULTRASTRUCTURE;

ADENOCARCINOMA; AGED; HUMANS; KERATINS; MALE; MIDDLE AGED; NECROSIS; NEOPLASM PROTEINS; PROSTATE; PROSTATECTOMY; PROSTATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; ULTRASONIC THERAPY;

EID: 0034075757     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.53.5.391     Document Type: Article

References (16)

1. 1 Bratt O, Elfving P, Flodgren P, et al. Morbidity of pelvic lymphadenectomy, radical retropubic prostatectomy and external radiotherapy in patients with localised prostatic cancer. Scand J Urol Nephrol 1994;28:265-71.
2. 2 Schwarzer JU, Hofmann R, Kneschaurek P, et al. High-dose-rate brachytherapy of prostatic carcinoma with iridium 192. Strahlenther Onkol 1992;168:17-22.
3. 3 Zippe CD. Cryosurgical ablation for prostate cancer: a current review. Semin Urol 1995;13:148-56.
4. 4 Pisters LL, von Eschenbach AC, Scott SM, et al. The efficacy and complications of salvage cryotherapy of the prostate. J Urol 1997;157:921-5.
5. 5 Ebert T, Graefen M, Miller S, et al. High-intensity focused ultrasound (HIFU) in the treatment of benign prostatic hyperplasia (BPH). Keio J Med 1995;44:146-9.
6. 6 Madersbacher S, Klingler CH, Schatzl G, et al. The urodynamic impact of transrectal high-intensity focused ultrasound on bladder outflow obstruction. Eur Urol 1996;30: 437-45.
7. 7 Mulligan ED, Lynch TH, Mulvin D, et al. High-intensity focused ultrasound in the treatment of benign prostatic hyperplasia. Br J Urol 1997;79:177-80.
8. 8 Sullivan LD, McLoughlin MG, Goldenberg LG, et al. Early experience with high-intensity focused ultrasound for the treatment of benign prostatic hyperplasia. Br J Urol 1997;79:172-6.
9. 9 Madersbacher S, Pedevilla M, Vingers L, et al. Effect of high-intensity focused ultrasound on human prostate cancer in vivo. Cancer Res 1995;55:3346-51.
10. 10 Gelet A, Chapelon JY, Bouvier R, et al. Treatment of prostate cancer with transrectal focused ultrasound: early clinical experience. Eur Urol 1996;29:174-83.
11. 11 Gelet A, Chapelon JY, Bouvier R, et al. Local control of prostate cancer by transrectal high intensity focused ultrasound therapy: preliminary results. J Urol 1999;161:156-62.
12. 12 Beerlage HP, Van Leenders GJLH, Oosterhof GON, et al. High-intensity focused ultrasound (HIFU) followed after one to two weeks by radical retropubic prostatectomy: results of a prospective study. Prostate 1999;39:41-6
13. 13 Susani M, Madersbacher S, Kratzik C, et al. Morphology of tissue destruction induced by focused ultrasound. Eur Urol 1993;23(suppl 1):34-8.
14. 14 Schröder FH, Hermanek P, Denis L, et al. The TNM classification of prostate cancer. Prostate 1992;(suppl 4):129-38.
15. 15 Overgaard K, Overgaard J. Hyperthermic tumour-cell devitalization in vivo. Acta Radiol Ther Phys Biol 1977;16:1-16
16. 16 Lepock JR, Frey HE, Ritchie KP. Protein denaturation in intact hepatocytes and isolated cellular organelles during heat shock. J Cell Biol 1993;122:1267-76.